- Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition2021 | Second Faculty of Medicine
- Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency2022 | Second Faculty of Medicine
- Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: A report from the International RRD Consortium2024 | Second Faculty of Medicine
- Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance2021 | Second Faculty of Medicine
